# DataMeds AI Secures Humana Medicaid Coverage for ChemoFx Test

- URL: https://stocks.freetheai.org/news/datameds-ai-secures-humana-medicaid-coverage-for-chemofx-test-f3dc6b
- Published: 2026-10-12T10:00:00Z
- Category: company_news; sentiment: mixed; impact: medium
- Symbols: [NASDAQ:MEDS](https://stocks.freetheai.org/symbols/NASDAQ-MEDS)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

DataMeds AI, Inc. (MEDS) has secured coverage from Humana for its ChemoFx assay under Medicaid policies for gynecologic cancers. The decision covers CPT codes 81535 and 81536, allowing healthcare providers to bill and track reimbursement for the test. However, the coverage does not apply across all Humana plans.

The policy update represents an initial reimbursement victory following the acquisition of Helomics by DataMeds AI, Inc. Adding ChemoFx to Medicaid policy provides a direct pathway for payer adoption, potentially expanding test volumes and generating new revenue. The company operates a CLIA-certified laboratory equipped with automated systems to manage higher testing demands. Despite the decision, shares fell 12.94% to $2.96.

Investors should monitor whether coverage expands to additional Medicaid regions, Medicare, or commercial insurers. Future financial reports detailing disclosed reimbursement rates and test volume trends will help determine the overall commercial impact of the assay.

## Key points

- Humana included the ChemoFx assay in its Medicaid Pharmacogenomics Testing policy for gynecologic cancers.
- Coverage utilizes CPT codes 81535 and 81536 to facilitate billing and reimbursement tracking.
- The policy update applies selectively and does not extend to all Humana healthcare plans.
- DataMeds AI, Inc. maintains automated, CLIA-certified laboratory capacity to handle potential demand growth.
- Shares of DataMeds AI, Inc. (MEDS) dropped 12.94% to $2.96 following the announcement.

## Questions and answers

### What is the new Medicaid coverage for DataMeds AI?

Humana added the ChemoFx assay to its Medicaid Pharmacogenomics Testing policy for gynecologic cancers under CPT codes 81535 and 81536.

### Does Humana cover ChemoFx under all of its plans?

No, the coverage update applies specifically to Medicaid plans for gynecologic cancers and is not available across all Humana plans.